Blog

Latest news and articles!

San Juan, Puerto Rico – February 11, 2025— Hemostemix PR Inc. proudly congratulates Luis Muñoz Marín International Airport (SJU) on achieving the prestigious CEIV Pharma Certification from the International Air Transport Association (IATA). This milestone

 Calgary, Alberta, February 10, 2025 – Hemostemix Inc. (TSXV:HEM, OTC:HMTXF, FSE:2VF0, “Hemostemix” or the “Company”) is excited to announce that it has engaged ProConsul Capital Ltd. (“ProConsul”), to provide investment marketing consulting services (the “Services”)

Calgary, Alberta, February 3, 2025 – Hemostemix Inc. (TSXV:HEM, OTC:HMTXF, FSE:2VF0, “Hemostemix” or the “Company”) is pleased to announce its continued expansion, as the Company brings its revolutionary ACP-01 therapy back to the Dominican Republic.

Calgary, Alberta, January 29, 2025 – Hemostemix Inc. (TSXV:HEM, OTC:HMTXF, FSE:2VF0, “Hemostemix” or the “Company”) is very pleased to announce that its sales of ACP-01 Treatments are gaining traction, following its social media campaign and

Calgary, Alberta, January 27, 2025 – Hemostemix Inc. (TSXV:HEM, OTC:HMTXF, FSE:2VF0, “Hemostemix” or the “Company”) is very pleased to announce that its shares  commenced trading on the TradeGateExchange.De under symbol 2VF0 today,  January 27, 2025.

Calgary, Alberta, January 20, 2025 – Hemostemix Inc. (TSXV:HEM, OTC:HMTXF, FSE:2VF0, “Hemostemix” or the “Company”) is proud to announce its participation in two highly anticipated Puerto Rico Investor Summits: Thomas Smeenk, President & CEO of

Calgary, Alberta, January 13, 2025 – Hemostemix Inc. (TSXV:HEM, OTC:HMTXF, FSE:2VF0, “Hemostemix” or the “Company”) is pleased to announce that the settlement of Hemostemix common share purchases via the Depository Trust Company (“DTC”) is now

Calgary, Alberta, January 9, 2025 – Hemostemix Inc. (TSXV:HEM, OTCQB:HMTXF, FSE:2VF0) is pleased to announce amendments to its Manufacturing Services Agreement with CytoImmune Therapeutics (“CytoImmune”). These amendments add Regulatory Consulting and Engineering Services and align

Calgary, Alberta, January 6, 2025. Hemostemix Inc. (“Hemostemix” or the “Company”, TSXV:HEM, FSE:2VF0, OTC:HMTXF), is pleased to announce it has incorporated Hemostemix PR Inc., in Puerto Rico, as a wholly owned subsidiary and a domestic

Calgary, Alberta, January 2, 2025. Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV:HEM; FSE:2VF0; OTC:HMTXF), is pleased to announce it has applied to up-list its shares on the OTCQB Venture Market.  Currently listed on the TSXV